Pieris Pharmaceuticals, Inc. (PIRS)

NASDAQ: PIRS · IEX Real-Time Price · USD

8.57

-1.13 (-11.65%)

At close: Jul 2, 2024, 4:00 PM

8.58

+0.01 (0.12%)

After-hours: Jul 2, 2024, 7:33 PM EDT

Pieris Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2013
Net Income	-24.54	-33.28	-45.74	-37.23	-28.3	Upgrade
Depreciation & Amortization	1.78	2.78	2.37	2.13	1.04	Upgrade
Share-Based Compensation	3.35	4.4	5.22	5.09	5.37	Upgrade
Other Operating Activities	-34.41	-33.84	30.5	-15.88	-33.41	Upgrade
Operating Cash Flow	-53.82	-59.93	-7.66	-45.9	-52.47	Upgrade
Capital Expenditures	-0.17	-1.04	-0.95	-2.73	-2.46	Upgrade
Change in Investments	12.17	-20.2	0	41.94	12.3	Upgrade
Investing Cash Flow	12	-21.24	-0.95	39.21	9.84	Upgrade
Share Issuance / Repurchase	19.8	7.21	59.13	10.12	32.17	Upgrade
Financing Cash Flow	19.8	7.21	59.13	10.12	32.17	Upgrade
Exchange Rate Effect	0.78	-5.18	-3.19	4.75	-2.14	Upgrade
Net Cash Flow	-21.24	-79.13	47.33	8.18	-12.61	Upgrade
Free Cash Flow	-53.99	-60.97	-8.61	-48.62	-54.93	Upgrade
Free Cash Flow Margin	-126.12%	-235.40%	-27.40%	-165.82%	-118.69%	Upgrade
Free Cash Flow Per Share	-47.96	-65.76	-10.67	-71.40	-86.80	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).